Literature DB >> 9379325

Periodontal status of HIV-1 and HIV-2 seropositive and HIV seronegative female commercial sex workers in Senegal.

C F Ndiaye1, C W Critchlow, P J Leggott, N B Kiviat, I Ndoye, P B Robertson, K N Georgas.   

Abstract

Comprehensive studies of 92 commercial sex workers in Senegal, Africa included an oral examination in which we obtained measurements of decayed, missing, and filled (DMF) teeth; plaque index; gingival index; recession; probing depth (PD); clinical attachment loss (CAL); and the presence of HIV-associated periodontal lesions, under conditions wherein the examiner was unaware of the subject's HIV status. Twenty-seven subjects (29%) were HIV seropositive, 19 of whom were positive for HIV-1, 7 positive for HIV-2, and 1 positive for both. Most subjects were not taking any medications and previous dental care was limited. HIV-seronegative and HIV-seropositive subjects were similar in mean age, number of DMF teeth, percentage of sites with visible plaque, and number of sites with recession. However, the frequency of sites with gingival bleeding, with PD > or = 6 mm, and with CAL > or = 6 mm was significantly greater in seropositive than seronegative subjects. No differences were observed between HIV-1 and HIV-2 positive subjects. About 26% of HIV-seropositive subjects and about 5% of the seronegative subjects exhibited at least one site with concurrent PD > or = 6 mm and CAL > or = 6 mm. HIV-associated periodontal lesions were seen in 3 HIV-seropositive subjects (2 linear gingival erythema, 1 necrotizing periodontitis). One HIV-seronegative subject exhibited necrotizing gingivitis. In this population with multiple risks to oral health, both HIV-1 and HIV-2 infections were associated with a significantly increased prevalence of periodontal disease.

Entities:  

Mesh:

Year:  1997        PMID: 9379325     DOI: 10.1902/jop.1997.68.9.827

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  7 in total

Review 1.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

2.  Characterizing traditionally defined periodontal disease in HIV+ adults.

Authors:  Lance T Vernon; Catherine A Demko; Christopher C Whalen; Michael M Lederman; Zahra Toossi; Mianda Wu; Yiping W Han; Aaron Weinberg
Journal:  Community Dent Oral Epidemiol       Date:  2009-07-14       Impact factor: 3.383

3.  Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.

Authors:  K Heitzinger; P S Sow; N M Dia Badiane; G S Gottlieb; I N'Doye; M Toure; N B Kiviat; S E Hawes
Journal:  Int J STD AIDS       Date:  2012-10       Impact factor: 1.359

4.  Cohort study of HIV-positive and -negative methamphetamine users.

Authors:  Vladimir W Spolsky; Jason Clague; Vivek Shetty
Journal:  J Am Dent Assoc       Date:  2018-04-21       Impact factor: 3.634

5.  Oral health and HIV infection among female sex workers in Abidjan, Côte d'Ivoire.

Authors:  Marcellin N Nouaman; David G Meless; Patrick A Coffie; Elise Arrivé; Boris K Tchounga; Didier K Ekouévi; Camille Anoma; Serge P Eholié; François Dabis; Antoine Jaquet
Journal:  BMC Oral Health       Date:  2015-12-02       Impact factor: 2.757

6.  Effect of Nadir CD4+ T cell count on clinical measures of periodontal disease in HIV+ adults before and during immune reconstitution on HAART.

Authors:  Lance T Vernon; Catherine A Demko; Denise C Babineau; Xuelei Wang; Zahra Toossi; Aaron Weinberg; Benigno Rodriguez
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

Review 7.  Epidemiology of HIV among female sex workers, their clients, men who have sex with men and people who inject drugs in West and Central Africa.

Authors:  Erin Papworth; Nuha Ceesay; Louis An; Marguerite Thiam-Niangoin; Odette Ky-Zerbo; Claire Holland; Fatou Maria Dramé; Ashley Grosso; Daouda Diouf; Stefan D Baral
Journal:  J Int AIDS Soc       Date:  2013-12-02       Impact factor: 5.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.